drugset / Trial / NCT00449501
A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to demonstrate whether subjects respond similarly to the Onset of Effect Questionnaire (OEQ) administered pre-dose versus post-dose, while receiving SYMBICORT® pMDI 80/4.5 μg x 2 actuations twice daily or budesonide HFA pMDI 80 μg x 2 actuations twice daily.
Timeline
- Start
- 2007-03
- Primary completion
- —
- Completion
- 2007-11
Outcome
Missed primary endpoint
paper No significant differences were observed in patients' reports of perception, either daily versus weekly or predose versus postdose. PMID 19995138 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 160 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 9 ug | Inhaled |